Abstract
Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic
Highlights
Breast and colorectal cancers are often detected through routine screening of asymptomatic individuals
This quality improvement study was approved by the University of California San Diego Aligning and Coordinating Quality Improvement, Research and Evaluation (ACQUIRE) Committee and was deemed exempt from institutional review board approval
We examined cancer staging for all patients at their first presentation to Moores Cancer Center at University of California San Diego Health for a new diagnosis of malignant neoplasm or a second opinion in 2019 and 2020
Summary
Breast and colorectal cancers are often detected through routine screening of asymptomatic individuals. Effective cancer screening has led to improvements in survival as a result of increased detection of earlier-stage cancer, while decreasing the incidence of late-stage cancer diagnoses.[1,2]. The ongoing COVID-19 pandemic has posed a substantial challenge in cancer care by disrupting cancer screening procedures such as mammograms and colonoscopies.[3]. We sought to compare the incidence of early- and late-stage breast and colorectal cancer diagnoses during vs before the COVID-19 pandemic among patients at our institution. Author affiliations and article information are listed at the end of this article
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
